FR2925902B1
(fr)
*
|
2008-01-02 |
2011-01-07 |
Sanofi Aventis |
DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
US8133897B2
(en)
|
2008-06-20 |
2012-03-13 |
H. Lundbeck A/S |
Phenylimidazole derivatives as PDE10A enzyme inhibitors
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
|
UA103195C2
(ru)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Производные пурина для применения в лечении аллергий, воспалительных и инфекционных заболеваний
|
EP2334675B1
(en)
|
2008-09-16 |
2014-03-26 |
Csir |
Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
US20100204265A1
(en)
*
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
SG10201402969QA
(en)
|
2009-03-27 |
2014-09-26 |
Merck Sharp & Dohme |
Inhibitors of hepatitis c virus replication
|
US20190127365A1
(en)
|
2017-11-01 |
2019-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus replication
|
EA201101619A1
(ru)
|
2009-05-15 |
2012-05-30 |
Новартис Аг |
Производные 5-пиридин-3-ил-1,3-дигидроиндол-2-она и их применение в качестве модуляторов альдостеронсинтазы и/или cyp11b1
|
ES2430088T3
(es)
|
2009-05-15 |
2013-11-18 |
Novartis Ag |
Derivados de benzoxazolona como inhibidores de aldosterona sintasa
|
BRPI1009637A2
(pt)
|
2009-06-05 |
2019-04-30 |
Cephalon, Inc |
composto, composição e uso de um composto
|
JP5819831B2
(ja)
|
2009-08-17 |
2015-11-24 |
インテリカイン, エルエルシー |
複素環式化合物およびそれらの使用
|
MX338041B
(es)
|
2009-09-25 |
2016-03-30 |
Oryzon Genomics Sa |
Inhibidores de demetilasa-1 especificos de lisina y su uso.
|
WO2011041713A2
(en)
*
|
2009-10-02 |
2011-04-07 |
Glaxosmithkline Llc |
Piperazinyl antiviral agents
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
WO2011050284A1
(en)
*
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Pyrazolylpyridine antiviral agents
|
NZ599597A
(en)
|
2009-10-30 |
2013-05-31 |
Janssen Pharmaceutica Nv |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
WO2011058766A1
(en)
*
|
2009-11-16 |
2011-05-19 |
Raqualia Pharma Inc. |
Aryl carboxamide derivatives as ttx-s blockers
|
WO2011097491A1
(en)
*
|
2010-02-04 |
2011-08-11 |
Glaxosmithkline Llc |
Benzimidazole antiviral agents
|
US9186337B2
(en)
|
2010-02-24 |
2015-11-17 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
EP2545050B1
(en)
*
|
2010-03-10 |
2014-08-13 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
ES2607081T3
(es)
|
2010-04-19 |
2017-03-29 |
Oryzon Genomics, S.A. |
Inhibidores de desmetilasa específica de lisina-1 y su uso
|
WO2012008508A1
(ja)
*
|
2010-07-14 |
2012-01-19 |
武田薬品工業株式会社 |
複素環化合物
|
EP2598480B1
(en)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
LT2598482T
(lt)
|
2010-07-29 |
2018-07-10 |
Oryzon Genomics, S.A. |
Demetilazės lsd1 inhibitoriai arilciklopropilamino pagrindu ir jų medicininis panaudojimas
|
EP2621279B1
(en)
|
2010-09-29 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
WO2012058125A1
(en)
|
2010-10-26 |
2012-05-03 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hepatitis c virus
|
JP5951625B2
(ja)
|
2010-11-24 |
2016-07-13 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークThe Trustees Of Columbia University In The City Of New York |
加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドrbp4アンタゴニスト
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
AR085509A1
(es)
|
2011-03-09 |
2013-10-09 |
Bayer Cropscience Ag |
Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
|
WO2012122716A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
|
US8748435B2
(en)
|
2011-04-01 |
2014-06-10 |
Novartis Ag |
Pyrazolo pyrimidine derivatives
|
ME03782B
(me)
|
2011-04-08 |
2021-04-20 |
Janssen Sciences Ireland Unlimited Co |
Derivati pirimidina za tretman virusnih infekcija
|
US9029389B2
(en)
*
|
2011-04-21 |
2015-05-12 |
Institut Pasteur Korea |
Anti-inflammation compounds
|
WO2012149157A2
(en)
|
2011-04-26 |
2012-11-01 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
MY157429A
(en)
|
2011-06-24 |
2016-06-15 |
Amgen Inc |
Trpm8 antagonists and their use in treatments
|
CA2839703A1
(en)
|
2011-06-24 |
2012-12-27 |
Amgen Inc. |
Trpm8 antagonists and their use in treatments
|
EA027418B1
(ru)
|
2011-06-27 |
2017-07-31 |
Янссен Фармацевтика Нв |
ПРОИЗВОДНЫЕ 1-АРИЛ-4-МЕТИЛ[1,2,4]ТРИАЗОЛО[4,3-a]ХИНОКСАЛИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБЫ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ ИХ, ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ
|
ES2693122T3
(es)
|
2011-07-22 |
2018-12-07 |
Glaxosmithkline Llc |
Composición
|
KR20140093209A
(ko)
|
2011-08-17 |
2014-07-25 |
글락소스미스클라인 엘엘씨 |
치료 방법
|
BR112014009306B1
(pt)
|
2011-10-20 |
2021-07-20 |
Oryzon Genomics S.A. |
Compostos de (hetero)aril ciclopropilamina como inibidores de lsd1
|
CA2849564C
(en)
|
2011-10-20 |
2020-10-20 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
CN107011346B
(zh)
|
2011-11-09 |
2020-06-16 |
爱尔兰詹森科学公司 |
用于治疗病毒感染的嘌呤衍生物
|
JPWO2013100018A1
(ja)
*
|
2011-12-28 |
2015-05-11 |
武田薬品工業株式会社 |
複素環化合物
|
EP2847200B1
(en)
|
2012-04-26 |
2017-03-29 |
Bristol-Myers Squibb Company |
Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
|
EP2855489B1
(en)
|
2012-04-26 |
2017-01-04 |
Bristol-Myers Squibb Company |
Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
|
PL2841437T3
(pl)
|
2012-04-26 |
2017-12-29 |
Bristol-Myers Squibb Company |
Pochodne imidazotiadiazolu i imidazopirazyny jako inhibitory receptora 4 (par4) aktywowanego proteazą do leczenia agregacji płytek
|
US9333202B2
(en)
|
2012-05-01 |
2016-05-10 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
|
RU2657540C2
(ru)
|
2012-06-26 |
2018-06-14 |
Янссен Фармацевтика Нв |
Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств
|
AU2013289284B2
(en)
|
2012-07-09 |
2017-03-30 |
Janssen Pharmaceutica Nv |
Inhibitors of phosphodiesterase 10 enzyme
|
BR112015000615B1
(pt)
|
2012-07-13 |
2022-05-31 |
Janssen Sciences Ireland Uc |
Purinas macrocíclicas para o tratamento de infecções virais e composição farmacêutica que as compreende
|
FR2993564B1
(fr)
|
2012-07-20 |
2014-08-22 |
Metabrain Res |
Derives d'imidazopyridine utiles dans le traitement du diabete
|
US8952009B2
(en)
|
2012-08-06 |
2015-02-10 |
Amgen Inc. |
Chroman derivatives as TRPM8 inhibitors
|
BR112015003098A2
(pt)
|
2012-08-17 |
2017-08-22 |
Bayer Cropscience Ag |
Azaindolecarboxamidas e azaindoletiocarboxamidas como inseticidas e acaricidas.
|
JP6196674B2
(ja)
|
2012-08-24 |
2017-09-13 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC |
ピラゾロピリミジン化合物
|
CN104837840B
(zh)
|
2012-10-10 |
2017-08-08 |
爱尔兰詹森科学公司 |
用于治疗病毒感染及其他疾病的吡咯并[3,2‑d]嘧啶衍生物
|
US10392389B2
(en)
|
2012-10-25 |
2019-08-27 |
Bioenergenix Llc |
Heterocyclic compounds for the inhibition of PASK
|
US9278973B2
(en)
|
2012-10-25 |
2016-03-08 |
Bioenergenix Llc |
Heterocyclic compounds for the inhibition of PASK
|
AU2013346793B2
(en)
|
2012-11-16 |
2018-03-08 |
Janssen Sciences Ireland Uc |
Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
|
CN104780922B
(zh)
|
2012-11-20 |
2016-09-07 |
葛兰素史克有限责任公司 |
干扰素诱导剂化合物
|
CN104780924B
(zh)
|
2012-11-20 |
2016-09-14 |
葛兰素史克有限责任公司 |
干扰素诱导剂化合物
|
WO2014081643A1
(en)
|
2012-11-20 |
2014-05-30 |
Glaxosmithkline Llc |
Novel compounds
|
JP6284490B2
(ja)
|
2012-12-28 |
2018-02-28 |
株式会社新日本科学 |
イミダゾピリジン誘導体を有効成分として含むoct3活性阻害剤又はoct3検出剤
|
WO2014110687A1
(en)
|
2013-01-16 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
|
BR112015019276A2
(pt)
|
2013-02-19 |
2017-07-18 |
Pfizer |
compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
|
KR102300861B1
(ko)
|
2013-02-21 |
2021-09-10 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
EP2963013A4
(en)
|
2013-02-27 |
2016-09-14 |
Shionogi & Co |
INDOLE AND AZAINDOLE DERIVATIVES HAVING AMPK ACTIVATION ACTIVITY EACH
|
US9637450B2
(en)
|
2013-03-14 |
2017-05-02 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
EP3495357B1
(en)
|
2013-03-14 |
2021-05-05 |
The Trustees of Columbia University in the City of New York |
4-phenylpiperidines, their preparation and use
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域(bromodomain)抑制劑之苯並咪唑酮衍生物類
|
JP6336036B2
(ja)
|
2013-03-29 |
2018-06-06 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染治療のための大環状デアザプリノン
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
JP6377139B2
(ja)
|
2013-05-24 |
2018-08-22 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症およびさらなる疾患の処置のためのピリドン誘導体
|
WO2014200882A1
(en)
|
2013-06-11 |
2014-12-18 |
Janssen Pharmaceutica Nv |
PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES
|
US9249163B2
(en)
|
2013-06-11 |
2016-02-02 |
Janssen Pharmaceutica Nv. |
PDE10a inhibitors for the treatment of type II diabetes
|
PL3030563T3
(pl)
|
2013-06-27 |
2018-01-31 |
Janssen Sciences Ireland Uc |
Pochodne pirolo [3,2-d] pirymidyny do leczenia zakażeń wirusowych i innych chorób
|
MX368625B
(es)
|
2013-07-30 |
2019-10-08 |
Janssen Sciences Ireland Uc |
Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales.
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
US9108953B2
(en)
|
2013-11-26 |
2015-08-18 |
Gilead Sciences, Inc. |
Quinoline derivatives as bromodomain inhibitors
|
US9969687B2
(en)
|
2013-12-23 |
2018-05-15 |
Norgine B.V. |
Compounds useful as CCR9 modulators
|
SG10201806849WA
(en)
|
2014-02-13 |
2018-09-27 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
TWI664164B
(zh)
|
2014-02-13 |
2019-07-01 |
美商英塞特控股公司 |
作為lsd1抑制劑之環丙胺
|
EP3105219B9
(en)
|
2014-02-13 |
2018-10-03 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
KR102429220B1
(ko)
|
2014-04-30 |
2022-08-04 |
더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 |
치환 4-페닐피페리딘, 그 제조 및 사용
|
EP3139743B1
(en)
|
2014-05-08 |
2018-03-14 |
Bayer CropScience Aktiengesellschaft |
Pyrazolopyridine sulfonamides as nematicides
|
US9617279B1
(en)
|
2014-06-24 |
2017-04-11 |
Bristol-Myers Squibb Company |
Imidazooxadiazole compounds
|
US9598419B1
(en)
|
2014-06-24 |
2017-03-21 |
Universite De Montreal |
Imidazotriazine and imidazodiazine compounds
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為lsd1抑制劑之咪唑并吡啶及咪唑并吡嗪
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
US10131669B2
(en)
|
2014-07-24 |
2018-11-20 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
DK3177624T3
(da)
|
2014-08-06 |
2019-07-01 |
Pfizer |
Imidazopyridazinforbindelser
|
EP3215505B1
(en)
|
2014-11-03 |
2019-07-24 |
Bayer Pharma Aktiengesellschaft |
Piperidinylpyrazolopyrimidinones and their use
|
TW201625635A
(zh)
|
2014-11-21 |
2016-07-16 |
默沙東藥廠 |
作為可溶性鳥苷酸環化酶活化劑之三唑并吡基衍生物
|
JP2018076234A
(ja)
*
|
2015-03-16 |
2018-05-17 |
大正製薬株式会社 |
ピラゾロ[1,5−a]ピリミジン化合物
|
JP6995623B2
(ja)
|
2015-04-03 |
2022-01-14 |
インサイト・コーポレイション |
Lsd1阻害剤としてのヘテロ環式化合物
|
JP6730309B2
(ja)
|
2015-04-08 |
2020-07-29 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
有害生物防除剤としての縮合二環式ヘテロ環誘導体及び中間体生成物
|
JO3637B1
(ar)
|
2015-04-28 |
2020-08-27 |
Janssen Sciences Ireland Uc |
مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
|
TWI765860B
(zh)
|
2015-08-12 |
2022-06-01 |
美商英塞特公司 |
Lsd1抑制劑之鹽
|
GB201521059D0
(en)
*
|
2015-11-30 |
2016-01-13 |
Isis Innovation |
Inhibitors of metallo-beta-lactamases
|
WO2017093180A1
(de)
|
2015-12-01 |
2017-06-08 |
Bayer Cropscience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
CN109311889B
(zh)
|
2016-04-15 |
2021-11-16 |
缆图药品公司 |
激活素受体样激酶抑制剂
|
MX2018012901A
(es)
|
2016-04-22 |
2019-06-06 |
Incyte Corp |
Formulaciones de inhibidor de demetilasa 1 especifica para lisina (lsd1).
|
EP3241830A1
(de)
|
2016-05-04 |
2017-11-08 |
Bayer CropScience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
CA3027500A1
(en)
*
|
2016-06-21 |
2017-12-28 |
X4 Pharmaceuticals, Inc. |
Cxcr4 inhibitors and uses thereof
|
JP7054529B2
(ja)
|
2016-06-21 |
2022-04-14 |
エックス4 ファーマシューティカルズ, インコーポレイテッド |
Cxcr4阻害剤およびその使用
|
WO2018002319A1
(en)
|
2016-07-01 |
2018-01-04 |
Janssen Sciences Ireland Uc |
Dihydropyranopyrimidines for the treatment of viral infections
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
EP3497102B1
(de)
|
2016-08-15 |
2022-12-07 |
Bayer CropScience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
ES2912945T3
(es)
|
2016-09-29 |
2022-05-30 |
Janssen Sciences Ireland Unlimited Co |
Profármacos de pirimidina para el tratamiento de infecciones virales y otras enfermedades
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
CN110312718B
(zh)
|
2017-01-10 |
2023-02-28 |
拜耳公司 |
作为害虫防治剂的杂环烯衍生物
|
MX2019008229A
(es)
|
2017-01-10 |
2019-10-24 |
Bayer Ag |
Derivados heterociclicos como agentes de control de plagas.
|
KR102616949B1
(ko)
|
2017-09-14 |
2023-12-22 |
다이이찌 산쿄 가부시키가이샤 |
고리형 구조를 갖는 화합물
|
KR20200094734A
(ko)
|
2017-09-22 |
2020-08-07 |
주빌런트 에피파드 엘엘씨 |
Pad 억제제로서의 헤테로사이클릭 화합물
|
EP3692045A1
(de)
|
2017-10-04 |
2020-08-12 |
Bayer Aktiengesellschaft |
Heterocyclen-derivate als schädlingsbekämpfungsmittel
|
DK3697785T3
(da)
|
2017-10-18 |
2023-04-03 |
Jubilant Epipad LLC |
Imidazo-pyridine forbindelser som pad-inhibitorer
|
WO2019079649A1
(en)
|
2017-10-18 |
2019-04-25 |
Blueprint Medicines Corporation |
SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-RELATED KINASE
|
AU2018362046B2
(en)
|
2017-11-06 |
2023-04-13 |
Jubilant Prodel LLC |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
CA3083374A1
(en)
|
2017-11-24 |
2019-05-31 |
Jubilant Episcribe Llc |
Heterocyclic compounds as prmt5 inhibitors
|
TW201932470A
(zh)
|
2017-11-29 |
2019-08-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
具有抗rsv活性之吡唑并嘧啶
|
EP3746444B1
(en)
|
2018-01-31 |
2023-09-27 |
Janssen Sciences Ireland Unlimited Company |
Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
|
ES2906077T3
(es)
|
2018-02-21 |
2022-04-13 |
Bayer Ag |
Derivados de heterociclos bicíclicos condensados como pesticidas
|
AU2019227607C1
(en)
|
2018-02-27 |
2023-07-20 |
Incyte Corporation |
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
|
TW201945003A
(zh)
|
2018-03-01 |
2019-12-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
2,4-二胺基喹唑啉衍生物及其醫學用途
|
ES2929476T3
(es)
|
2018-03-12 |
2022-11-29 |
Bayer Ag |
Derivados heterocíclicos bicíclicos condensados como plaguicidas
|
AU2019234185A1
(en)
|
2018-03-13 |
2020-10-01 |
Jubilant Prodel LLC. |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation
|
EP3765459A1
(en)
|
2018-03-13 |
2021-01-20 |
Shire Human Genetic Therapies, Inc. |
Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof
|
GB201806320D0
(en)
|
2018-04-18 |
2018-05-30 |
Cellcentric Ltd |
Process
|
JP2021522182A
(ja)
|
2018-04-20 |
2021-08-30 |
バイエル・アクチエンゲゼルシヤフト |
殺有害生物剤としてのヘテロシクレン誘導体
|
EA202092439A1
(ru)
|
2018-04-23 |
2021-03-05 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Гетероароматические соединения, обладающие активностью против rsv
|
EA202092779A1
(ru)
|
2018-05-17 |
2021-02-02 |
Байер Акциенгезельшафт |
Замещенные дигидропиразолопиразинкарбоксамидные производные
|
JP7391046B2
(ja)
|
2018-05-18 |
2023-12-04 |
インサイト・コーポレイション |
A2a/a2b阻害剤としての縮合ピリミジン誘導体
|
CN117304191A
(zh)
|
2018-07-05 |
2023-12-29 |
因赛特公司 |
作为a2a/a2b抑制剂的稠合吡嗪衍生物
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
RS65335B1
(sr)
|
2018-10-05 |
2024-04-30 |
Annapurna Bio Inc |
Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću receptora apj
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
CN111518102B
(zh)
*
|
2019-05-14 |
2023-09-05 |
南京工业大学 |
环基甲酰及环基酮类化合物及其制备方法和药学上的用途
|
CN114667289A
(zh)
|
2019-09-18 |
2022-06-24 |
武田药品工业有限公司 |
杂芳基血浆激肽释放酶抑制剂
|
JP2022548696A
(ja)
|
2019-09-18 |
2022-11-21 |
武田薬品工業株式会社 |
血漿カリクレインインヒビター及びその使用
|
MX2022003217A
(es)
|
2019-09-19 |
2022-06-29 |
Totus Medicines Inc |
Conjugados terapeuticos.
|
AU2021267373A1
(en)
|
2020-05-06 |
2022-12-08 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
|
IL301739A
(en)
|
2020-10-05 |
2023-05-01 |
Enliven Therapeutics Inc |
5- and 6-Azaindole compounds for inhibition of BCR-ABL tyrosine kinases
|
WO2022087422A1
(en)
*
|
2020-10-22 |
2022-04-28 |
Chulalongkorn University |
Pyrrolidine-3-carboxamide derivatives and related uses
|
WO2023057394A1
(en)
|
2021-10-04 |
2023-04-13 |
Forx Therapeutics Ag |
N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer
|
AU2022388555A1
(en)
|
2021-11-09 |
2024-05-02 |
Ajax Therapeutics, Inc. |
6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
CN117402156A
(zh)
*
|
2022-07-08 |
2024-01-16 |
中国科学院上海药物研究所 |
一类酰胺化合物及其制备方法、药物组合物和用途
|